Cedars-Sinai Medical Center - UCLA School of Medicine

Samuel Oschin Comprehensive Cancer Institute

Los Angeles, CA

Sorting 1 by

Accepting patients

Iberdomide vs. Observation Post Ide-Cel CAR-T

Randomized Phase 2 Study of Iberdomide Maintenance Therapy Following Idecabtagene Vicleucel CAR-T in Multiple Myeloma Patients
Learn more
  • CELMoD
  • Maintenance
  • Randomization
  • Phase 2
  • Myeloma Service